CA1150245A - N-trifluoroacetyladriamycin-14-o-hemiglutarate and - hemiadipate and therapeutic compositions containing same - Google Patents
N-trifluoroacetyladriamycin-14-o-hemiglutarate and - hemiadipate and therapeutic compositions containing sameInfo
- Publication number
- CA1150245A CA1150245A CA000379303A CA379303A CA1150245A CA 1150245 A CA1150245 A CA 1150245A CA 000379303 A CA000379303 A CA 000379303A CA 379303 A CA379303 A CA 379303A CA 1150245 A CA1150245 A CA 1150245A
- Authority
- CA
- Canada
- Prior art keywords
- trifluoroacetyladriamycin
- hemiadipate
- hemiglutarate
- preparation
- trifluoroacetyldaunomycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US157,861 | 1980-06-09 | ||
| US06/157,861 US4299822A (en) | 1980-06-09 | 1980-06-09 | N-Trifluoroacetyladriamycin-14-O-hemiglutarate and -hemiadipate and therapeutic compositions containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1150245A true CA1150245A (en) | 1983-07-19 |
Family
ID=22565590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000379303A Expired CA1150245A (en) | 1980-06-09 | 1981-06-08 | N-trifluoroacetyladriamycin-14-o-hemiglutarate and - hemiadipate and therapeutic compositions containing same |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4299822A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5767596A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1150245A (cg-RX-API-DMAC10.html) |
| CH (1) | CH645387A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE3122689C2 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2483928A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB2077265B (cg-RX-API-DMAC10.html) |
| NL (1) | NL184420C (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4610977A (en) * | 1985-04-08 | 1986-09-09 | The University Of Tennessee Research Corporation | N-alkyl and N-benzyl adriamycin derivatives |
| US5843903A (en) * | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
| RU2758670C1 (ru) * | 2020-12-30 | 2021-11-01 | федеральное государственное бюджетное образовательное учреждение высшего образования «Приволжский исследовательский медицинский университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО "ПИМУ" Минздрава России) | Новое химическое соединение 5-фторурацила и доксорубицина |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2135221A1 (en) * | 1971-05-04 | 1972-12-15 | Farmaceutici Italia | Doxorubicin 14-esters prepn - by treating 14-bromodaunomycin with a salt of the corresp acid |
| GB1368680A (en) * | 1972-12-09 | 1974-10-02 | Farmaceutici Italia | Adriamycin derivatives |
| US4035566A (en) * | 1975-09-25 | 1977-07-12 | Sidney Farber Cancer Institute, Inc. | N-trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same |
| GB1567456A (en) * | 1976-11-16 | 1980-05-14 | Farmaceutici Italia | Daunomycin derivatives |
-
1980
- 1980-06-09 US US06/157,861 patent/US4299822A/en not_active Expired - Lifetime
-
1981
- 1981-06-03 CH CH364481A patent/CH645387A5/de not_active IP Right Cessation
- 1981-06-05 NL NLAANVRAGE8102730,A patent/NL184420C/xx not_active IP Right Cessation
- 1981-06-06 DE DE3122689A patent/DE3122689C2/de not_active Expired
- 1981-06-08 CA CA000379303A patent/CA1150245A/en not_active Expired
- 1981-06-08 GB GB8117474A patent/GB2077265B/en not_active Expired
- 1981-06-09 FR FR8111336A patent/FR2483928A1/fr active Granted
- 1981-06-09 JP JP56088773A patent/JPS5767596A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2483928B1 (cg-RX-API-DMAC10.html) | 1984-01-06 |
| FR2483928A1 (fr) | 1981-12-11 |
| CH645387A5 (de) | 1984-09-28 |
| GB2077265B (en) | 1984-01-11 |
| DE3122689A1 (de) | 1982-05-06 |
| US4299822A (en) | 1981-11-10 |
| GB2077265A (en) | 1981-12-16 |
| NL8102730A (nl) | 1982-01-04 |
| DE3122689C2 (de) | 1985-07-04 |
| JPS632440B2 (cg-RX-API-DMAC10.html) | 1988-01-19 |
| JPS5767596A (en) | 1982-04-24 |
| NL184420C (nl) | 1989-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0151189B1 (en) | Antineoplastic agent | |
| AU621470B2 (en) | Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents | |
| US4658058A (en) | 11-O-methylspergualin | |
| US4035566A (en) | N-trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same | |
| RU2074185C1 (ru) | Производное 4-дезокси-4-эпиподофиллотоксина или его фармацевтически приемлемая соль и фармацевтическая композиция на его основе | |
| DE69710573T2 (de) | Morpholinyl-anthracyclinderivate | |
| US5036103A (en) | Method of treating cancer cells in humans | |
| DE69912058T2 (de) | Proaktive antitumore Verbindungen | |
| JPH05247078A (ja) | 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体 | |
| CA1150245A (en) | N-trifluoroacetyladriamycin-14-o-hemiglutarate and - hemiadipate and therapeutic compositions containing same | |
| EP0227844B1 (en) | Antiviral drug | |
| US4831053A (en) | Composition for prophylaxis and therapy of hepatitis | |
| US4131649A (en) | Daunorubicin derivatives, their preparation and their use | |
| US4075328A (en) | Naphthacene derivatives | |
| US5753695A (en) | Flavilium compounds and method of using | |
| EP0378706B1 (en) | 5-substituted uridine derivatives and intermediates for their preparation | |
| US4104461A (en) | 2,2'-Anhydro-β-D-arabinofuranosyl-5-fluorocytosine | |
| US5026732A (en) | Use of avarone for the control of AIDS and ARC | |
| US5922838A (en) | Cyclic hexapeptide compounds | |
| EP0196330B1 (de) | Verwendung von pyrrothinderivaten | |
| EP0080305A1 (en) | Antiviral 2'-deoxyuridines, their preparation and use | |
| KR100398289B1 (ko) | 신규 안트라사이클린 유도체 및 그 제조방법 | |
| AU665488B2 (en) | New compound, leustroducsin H, its preparation and its therapeutic use | |
| US4978783A (en) | 2,6-dimethoxyhydroquinone-3-mercaptopropionic acid, 2,6-dimethoxyhydroquinone-3-mercaptoacetic acid, and antitumor use thereof | |
| EP0365176A1 (en) | Ellipticine glycoside derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |